Intraocular Pressure Changes after Intravitreal Bevacizumab or Ranibizumab Injection: A Retrospective Study

PURPOSE: To determine intraocular pressure (IOP) changes after intravitreal bevacizumab or ranibizumab injection administered for various retinal disorders. METHODS: A retrospective chart review of 796 eyes of 574 patients receiving intravitreal ranibizumab (0.5 mg) and/or bevacizumab (1.25 mg) inje...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Curr Ophthalmol
Asıl Yazarlar: Mansoori, Tarannum, Agraharam, Satish Gooty, Manwani, Sunny, Balakrishna, Nagalla
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer - Medknow 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102956/
https://ncbi.nlm.nih.gov/pubmed/34084950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/JOCO.JOCO_5_20
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller